Open an account

American Well

AMWL · NYSE

$13.20+$0.87 (+7.06%)TodayMarket closed ·
Prev close $12.33

About AMWL

American Well Corp. engages in the provision of online healthcare services. The company is headquartered in Boston, Massachusetts and currently employs 562 full-time employees. The company went IPO on 2020-09-17. The company offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. The Amwell Converge platform offers data architecture and video capabilities, flexibility and scalability, as well as a user experience focused on the needs of patients, members and providers. For health systems, its enterprise platform enables provider-to-provider virtual care for use cases ranging from stroke to virtual nursing and e-sitting. Its Amwell Carepoint devices enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings, helping to address personnel shortages and access limitations.

Employees
562
Headquarters
Boston, Massachusetts
Listed
Sep 17, 2020
Sector
Health Care
Industry
Health Care Technology
Website
business.amwell.com

AMWL key statistics

Market cap
209.72M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
99.30K
Volume
119.22K
Open price
$12.25
High today
$13.30
Low today
$12.25
52 Week high
$14.19
52 Week low
$3.71

American Well (AMWL) at a glance

American Well (AMWL) last traded at $13.20, with a market cap of 209.72M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $12.25 and $13.30. The current price is 7.8% above the day's low and 0.8% below its high.

Volume so far is 119.22K shares, above the average of 99.30K shares a day.

Over the past year American Well has ranged from $3.71 to $14.19, and now sits 91% of the way up that range.

American Well met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported -$0.59 per share against an estimate of -$0.8772.

The average analyst price target is $12.58, 4.7% below the current price, from 6 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

17%of 6 analyst ratings say Buy
  • Buy16.7%
  • Hold83.3%
  • Sell0.0%
Price target · 8 analystsAvg $12.58
Low
$10.10
Now
$13.20
High
$16.80

AMWL earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 25.5% on average.

  1. Q3 FY24: reported -$2.87 per share against an estimate of -$3.46
  2. Q4 FY24: reported -$2.77 per share against an estimate of -$2.99
  3. Q1 FY25: reported -$1.88 per share against an estimate of -$2.73
  4. Q2 FY25: reported -$1.24 per share against an estimate of -$1.78
  5. Q3 FY25: reported -$2.00 per share against an estimate of -$1.83
  6. Q4 FY25: reported -$1.52 per share against an estimate of -$1.81
  7. Q1 FY26: reported -$0.66 per share against an estimate of -$1.18
  8. Q2 FY26: reported -$0.59 per share against an estimate of -$0.8772

AMWL news

  • 12 Health Care Stocks Moving In Wednesday's Intraday Session

  • 12 Health Care Stocks Moving In Tuesday's After-Market Session

  • Earnings Scheduled For August 5, 2025

  • What Analysts Are Saying About American Well Stock

  • Breaking Down American Well: 4 Analysts Share Their Views

  • 12 Health Care Stocks Moving In Thursday's After-Market Session

  • Insights Ahead: American Well's Quarterly Earnings

  • A Glimpse Into The Expert Outlook On American Well Through 4 Analysts

Similar companies

Companies in the same industry as American Well

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.